Frequency and antimicrobial susceptibility pattern of methicillin resistant Staphylococcus aureus

Journal of the College of Physicians and Surgeons Pakistan

Volumn 19, Issue 5, 2009, Pages 287-290

  Malik, Nasrullah ^a,b   Butt, Tariq ^b   Arfan ul Bari, ^a  

^a Combined Military Hospital ^*  (Pakistan)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

MRSA; Staphylococcus aureus; Vancomycin

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; METICILLIN; OXACILLIN; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; COMMUNITY; CROSS-SECTIONAL STUDY; DISK DIFFUSION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PAKISTAN; PENICILLIN RESISTANCE; PUBLIC HOSPITAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PAKISTAN; PREVALENCE; STAPHYLOCOCCAL INFECTIONS;

EID: 66949116379     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Marchese A, Sachito GC, Debbia EA. Evolution of antibiotic resistance in gram-positive pathogens. J Chemother 2000; 12: 459-462 (Pubitemid 32048159)
2. WHO, External quality assessment in microbiology. WHO collaborating centre for external quality assessment in clinical microbiology. Leuven: WHO; 1977.
3. Qureshi AH, Hannan A. The prevalence and susceptibility pattern of methicillin resistant Staphylococcus aureus. Pak J Pathol 1991; 2:41-44
4. Archer GL. Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 1998; 26:1179-1181 (Pubitemid 28215485)
5. Brown DFJ. Detection of methicillin/oxacillin resistance in staphylococci. J Antimicrob Chemother 2001; 48:65-70. (Pubitemid 33735467)
6. Hanssen AM, Kjeldsen G, Sollid JU. Local variants of staphylococcal cassette chromosome mec in sporadic methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci: evidence of horizontal gene transfer? Antimicrob Agents Chemother 2004; 48:285-296 (Pubitemid 38040210)
7. Tabaqchali S. Vancomycin-resistant Staphylococcus aureus. apocalypse now? Lancet 1997; 350:1644-1645
8. Assadullah S, Kakru DK, Thoker MA, Bhat FA, Hussain N, Shah A. Emergence of low-level vancomycin resistance in MRSA. Indian J Med Microbiol 2003; 21:196-198 (Pubitemid 38008735)
9. Lentino JR, Narita M, Yu VL. New antimicrobial agents as therapy for resistant gram-positive cocci. Eur J Clin Microbiol Infect Dis 2008; 27:3-15. (Pubitemid 350197870)
10. Hall GS, Shresthå R, Vogel G, Methicillin/oxacillin-resistant S. aureus (MRSA/ORSA): laboratory detection in 2004. BD Lab Microbiol News Ideas 2004; 5(15):2.
11. Stevens CL, Ralph A, McLeod JET, McDonald M. Community-acquired methicillin-resistant Staphylococcus aureus in Central Australia. Commun Dis Intell 2006; 30:462-466
12. Coombs GW, Nimmo GR, Bell JM, Huygens F, O'Brien FG, Malkowski MJ, et al. Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. J Clin Microbiol 2004; 42: 4735-4743 (Pubitemid 39362396)
13. Clinical and Laboratory Standards Institute (CLSI). Performance standard for antimicrobial disk susceptibility tests; approved standard. 9th ed. M2-A9. Wayne, PA: The Committee; 2006.
14. CLSI performance standards for antimicrobial susceptibility testing. CLSI approved standard M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA; Clin Lab Stand Inst 2005.
15. Klimk JJ. Methicillin resistant Staphylococcus aureus. An important emerging pathogen. Highlights from: Infect Surgery 1984; 1:11-15
16. Ashiq B, Tareen AK. Methicillin resistant Staphylococcus aureus in a teaching hospital of Karachi: a laboratory study. J Pak Med Assoc 1989; 39:6-9. (Pubitemid 19078750)
17. Louie L, Matsumura SO, Choi E, Louie M, Simor AE. Evaluation of three rapid methods for detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol 2000; 38:2170-2173
18. Gosbell IB. Epidemiology, clinical features and management of infections due to community methicillin resistant Staphylococcus aureus (cMRSA). Intern Med J 2005; 35 (Suppl 2):S120-35.
19. Tomasz A, Nachman S, Leaf H. Stable classes of phenotypic expression in methicillin-resistant clinical isolates of Staphylococci. Antimicrob Agents Chemother 1991; 35:124-129
20. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350:1670-1673 (Pubitemid 28036828)
21. Poly MC, Grelaud C, Martin C, de Lumly L, Denis F. First clinical isolate of vancomycin intermediate Staphylococcus aureus in a France hospital. Lancet 1998; 351:1212. (Pubitemid 28171844)
22. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide intermediate Staphylococcus aureus working group. N Engl J Med 1999; 304: 493-501.
23. Trakulosomboon S, Danchairijitr S, Rongrungruang Y, Dhiraputra C, Susaemgrat W, Ito T, et al. First report of methicillin resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. J Clin Microbiol 2001; 33:591-595 (Pubitemid 32150823)
24. Borer A, Gilad J, Yagupsky P, Peled N, Porat N, Trefler R, et al. Community acquired methicillin resistant Staphylococcus aureus in institutionalized adults with developmental disabilities. Emerg Infect Dis 2002; 8:966-970 (Pubitemid 35000817)
25. Opal SM, Mayer KH, Medeiros AA. Mechanism of bacterial antibiotic resistance. In: Mandell GL, Bennet JE, Dolin R, (edi). Principles and practice of infectious diseases. 5th ed. Philadelphia: Churchil Livingstone; 2000: p.236-253
26. Hastings JG. Vancomycin resistance. J Med Microbiol 1997; 46:449-451
27. Recommendations for preventing the spread of vancomycin resistance. Hospital infection control practices advisory committee (HICPAC). Infect Control Hosp Epidemiol 1995; 16: 105-113
28. Nagarajan R. Anti-bacterial activities of and modes of action of vancomycin and related glycopeptides. Antimicrob Agents Chemother 1991; 35:605-609
29. Swenson JM, Patel JB, Jorgensen JH. Special phenotypic methods for detecting antibacterial resistance. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, (edi). Manual of clinical microbiology. 9th ed. Washington, D.C: ASM Press; 2007: p.1173-1185
30. Tenover FC, Lancaster MV, Hill BC, Steward CD, Stocker SA, Henock GA, et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 1998; 1020-1027 (Pubitemid 28146289)
31. Latif S, Anwar MS, Chaudhry NA, Susceptibility pattern of nosocomial methicillin-resistant S. aureus (MRSA) isolates to vancomycin and other anti-staphylococcal antibiotics. Biomedica 2000; 16:32-35
32. Anwar MS, Bokhari SR. Antimicrobial resistance of community and hospital acquired Staphylococcus aureus isolates to oxacillin and glycopeptides. J Coll Physicians Surg Pak 2003; 13:33-36 (Pubitemid 36416880)
33. Nishjima S, Kurokawa I, Antimicrobial resistance of Staphylococcus aureus isolated from skin infections. Int J Antimicrobiol Agents 2002; 19:241-243 (Pubitemid 34249807)